These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [New quinolones, current therapies]. Auckenthaler R Schweiz Rundsch Med Prax; 1988 Nov; 77(45):1217-8. PubMed ID: 2847274 [No Abstract] [Full Text] [Related]
10. Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance. Schmitz FJ; Higgins PG; Mayer S; Fluit AC; Dalhoff A Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):647-59. PubMed ID: 12373497 [TBL] [Abstract][Full Text] [Related]
11. Mode of action of new quinolones: the inhibitory activity on DNA gyrase. Sato K; Hoshino K; Mitsuhashi S Prog Drug Res; 1992; 38():121-32. PubMed ID: 1319080 [No Abstract] [Full Text] [Related]
12. Synthesis and antibacterial activity of novel 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxoquinoline-3-carboxylic acids bearing cyclopropane-fused 2-amino-8-azabicyclo[4.3.0]nonan-8-yl substituents at the C-7 position. Inagaki H; Takahashi H; Takemura M Bioorg Med Chem Lett; 2004 Oct; 14(20):5193-8. PubMed ID: 15380226 [TBL] [Abstract][Full Text] [Related]
13. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients. Rolston KV; Yadegarynia D; Kontoyiannis DP; Raad II; Ho DH Int J Infect Dis; 2006 May; 10(3):223-30. PubMed ID: 16439177 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of drug inhibition of DNA gyrase. Lewis RJ; Tsai FT; Wigley DB Bioessays; 1996 Aug; 18(8):661-71. PubMed ID: 8760340 [TBL] [Abstract][Full Text] [Related]
15. [Recent development in quinolone compounds antitumor quinolones]. Yang YS; Zhao SR; Ji RY; Chen KX Yao Xue Xue Bao; 1998; 33(2):157-60. PubMed ID: 11938953 [No Abstract] [Full Text] [Related]
17. [How are quinolones used in clinical practice? Gyrase antagonists from the viewpoint of the hospital pharmacist]. Schurz JK Pharm Unserer Zeit; 2001; 30(5):400-5. PubMed ID: 11575176 [No Abstract] [Full Text] [Related]
18. [Mechanisms of pandrug-resistance of Pseudomonas aeruginosa]. Shen JL; Zhu DM; Wang MG Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1859-62. PubMed ID: 19040025 [TBL] [Abstract][Full Text] [Related]
19. [Mechanisms of bacterial resistance to quinolones]. Taléns-Visconti R; Garrigues TM; Cantón E Rev Esp Quimioter; 2002 Mar; 15(1):25-31. PubMed ID: 12582434 [TBL] [Abstract][Full Text] [Related]
20. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Cholongitas E; Papatheodoridis GV; Lahanas A; Xanthaki A; Kontou-Kastellanou C; Archimandritis AJ Liver Int; 2005 Feb; 25(1):57-61. PubMed ID: 15698399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]